DD131562A5 - Verfahren zur herstellung von 5-pregnen-derivaten - Google Patents
Verfahren zur herstellung von 5-pregnen-derivatenInfo
- Publication number
- DD131562A5 DD131562A5 DD7600200192A DD20019276A DD131562A5 DD 131562 A5 DD131562 A5 DD 131562A5 DD 7600200192 A DD7600200192 A DD 7600200192A DD 20019276 A DD20019276 A DD 20019276A DD 131562 A5 DD131562 A5 DD 131562A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- pregen
- derivatives
- preparing
- pregen derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/005—Degradation of the lateral chains at position 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2534911A DE2534911C2 (de) | 1975-08-01 | 1975-08-01 | Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD131562A5 true DD131562A5 (de) | 1978-07-05 |
Family
ID=5953265
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD7600200192A DD131562A5 (de) | 1975-08-01 | 1976-07-30 | Verfahren zur herstellung von 5-pregnen-derivaten |
| DD7600200193A DD131561A5 (de) | 1975-08-01 | 1976-07-30 | Verfahren zur herstellung von 5-androsten-derivaten |
| DD194155A DD127114A5 (fr) | 1975-08-01 | 1976-07-30 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD7600200193A DD131561A5 (de) | 1975-08-01 | 1976-07-30 | Verfahren zur herstellung von 5-androsten-derivaten |
| DD194155A DD127114A5 (fr) | 1975-08-01 | 1976-07-30 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4170518A (fr) |
| JP (1) | JPS5238090A (fr) |
| AT (1) | AT361639B (fr) |
| BE (1) | BE844745A (fr) |
| CH (1) | CH624415A5 (fr) |
| CS (1) | CS191981B2 (fr) |
| DD (3) | DD131562A5 (fr) |
| DE (1) | DE2534911C2 (fr) |
| DK (1) | DK140172C (fr) |
| FR (1) | FR2319650A1 (fr) |
| GB (1) | GB1576129A (fr) |
| HU (1) | HU183019B (fr) |
| IE (1) | IE44308B1 (fr) |
| IT (1) | IT1065955B (fr) |
| NL (1) | NL7608540A (fr) |
| SE (1) | SE420731B (fr) |
| SU (1) | SU697053A3 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2632677A1 (de) * | 1976-07-16 | 1978-01-26 | Schering Ag | Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung |
| ATE275957T1 (de) * | 1993-01-19 | 2004-10-15 | Endorech Inc | Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron |
| US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
| WO1999007381A1 (fr) * | 1997-08-11 | 1999-02-18 | Weider Nutrition International, Inc. | Compositions et traitements permettant de reduire les effets secondaires lies a l'administration des precurseurs de la testosterone androgenique |
| EP1149839A1 (fr) * | 2000-04-28 | 2001-10-31 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. | Progestérone substantiellement exempte de delta-14-pregnen-3,20-dione |
| KR100432054B1 (ko) * | 2001-05-11 | 2004-05-17 | (주)유진사이언스 | 스테롤로부터 4-안드로스텐-3,17-디온/안드로스타-1,4-디엔-3,17-디온으로의 뛰어난 전환능을 가지는 미생물 및 이의 제조방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3684657A (en) * | 1970-05-11 | 1972-08-15 | Searle & Co | Selective microbiological degradation of steroidal 17-alkyls |
| US3759791A (en) * | 1970-12-10 | 1973-09-18 | Searle & Co | Selective microbiological preparation of androst-4-ene-3,17-dione |
-
1975
- 1975-08-01 DE DE2534911A patent/DE2534911C2/de not_active Expired
-
1976
- 1976-07-28 IT IT25774/76A patent/IT1065955B/it active
- 1976-07-28 CH CH965676A patent/CH624415A5/de not_active IP Right Cessation
- 1976-07-29 SE SE7608575A patent/SE420731B/xx not_active IP Right Cessation
- 1976-07-30 NL NL7608540A patent/NL7608540A/xx not_active Application Discontinuation
- 1976-07-30 SU SU762386219A patent/SU697053A3/ru active
- 1976-07-30 CS CS765024A patent/CS191981B2/cs unknown
- 1976-07-30 HU HU76SCHE574A patent/HU183019B/hu not_active IP Right Cessation
- 1976-07-30 DD DD7600200192A patent/DD131562A5/xx unknown
- 1976-07-30 DD DD7600200193A patent/DD131561A5/xx unknown
- 1976-07-30 US US05/710,559 patent/US4170518A/en not_active Expired - Lifetime
- 1976-07-30 DD DD194155A patent/DD127114A5/xx unknown
- 1976-07-30 DK DK343976A patent/DK140172C/da not_active IP Right Cessation
- 1976-07-30 BE BE169437A patent/BE844745A/fr not_active IP Right Cessation
- 1976-07-30 AT AT565676A patent/AT361639B/de not_active IP Right Cessation
- 1976-08-02 JP JP51092252A patent/JPS5238090A/ja active Granted
- 1976-08-02 GB GB32105/76A patent/GB1576129A/en not_active Expired
- 1976-08-02 FR FR7623557A patent/FR2319650A1/fr active Granted
- 1976-08-03 IE IE1710/76A patent/IE44308B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BE844745A (fr) | 1977-01-31 |
| AT361639B (de) | 1981-03-25 |
| SU697053A3 (ru) | 1979-11-05 |
| JPS5238090A (en) | 1977-03-24 |
| ATA565676A (de) | 1980-08-15 |
| CS191981B2 (en) | 1979-07-31 |
| JPS6253160B2 (fr) | 1987-11-09 |
| CH624415A5 (fr) | 1981-07-31 |
| IT1065955B (it) | 1985-03-04 |
| DK140172B (da) | 1979-07-02 |
| FR2319650B1 (fr) | 1980-05-09 |
| NL7608540A (nl) | 1977-02-03 |
| SE7608575L (sv) | 1977-02-02 |
| DD127114A5 (fr) | 1977-09-07 |
| DK140172C (da) | 1979-11-26 |
| IE44308B1 (en) | 1981-10-21 |
| SE420731B (sv) | 1981-10-26 |
| US4170518A (en) | 1979-10-09 |
| HU183019B (en) | 1984-04-28 |
| IE44308L (en) | 1977-02-01 |
| DE2534911A1 (de) | 1977-02-17 |
| FR2319650A1 (fr) | 1977-02-25 |
| DD131561A5 (de) | 1978-07-05 |
| DE2534911C2 (de) | 1985-04-18 |
| DK343976A (da) | 1977-02-02 |
| GB1576129A (en) | 1980-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD130857A5 (de) | Verfahren zur herstellung von n-phosphonomethylglycintriestern | |
| DD129006A5 (de) | Verfahren zur herstellung von pyrimidinderivaten | |
| DD137107A5 (de) | Verfahren zur herstellung von spiro-hydantoinderivaten | |
| AT354447B (de) | Verfahren zur herstellung von indolderivaten | |
| DD127966A5 (de) | Verfahren zur herstellung von pyrrolidinderivaten | |
| DD128812A5 (de) | Verfahren zur herstellung von chinazolonderivaten | |
| DD127901A5 (de) | Verfahren zur herstellung von mercaptoazetidin-derivaten | |
| DD134530A5 (de) | Verfahren zur herstellung von n-thiolcarbonylderivaten von n-phosphonomethylglycin | |
| DD129330A5 (de) | Verfahren zur herstellung von antitumorsubstanzen | |
| AT351187B (de) | Verfahren zur herstellung von 7-dehydrochol- esterinderivaten | |
| AT344147B (de) | Verfahren zur herstellung von acylcyaniden | |
| DD130576A5 (de) | Verfahren zur herstellung von derivaten von 5-hydroxy-chininzarinchinon | |
| DD130036A5 (de) | Verfahren zur herstellung von optisch aktiven 11-desoxy-16-aryloxy-omega-tetranorprostaglandinen | |
| DD129334A5 (de) | Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten | |
| DD128590A5 (de) | Verfahren zur herstellung optisch aktiver 11-desoxy-16-aryl-omega-tetranorprostaglandine | |
| DD129326A5 (de) | Verfahren zur herstellung von 1,4-diphenyl-3-pyrazolin-5-onen | |
| ATA314576A (de) | Verfahren zur herstellung von 4-nideralkyl-5- cyano-oxazolen | |
| DD137584A5 (de) | Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten | |
| AT349032B (de) | Verfahren zur herstellung von 4-alkyl-thiosemicarbaziden | |
| DD131562A5 (de) | Verfahren zur herstellung von 5-pregnen-derivaten | |
| DD122961A5 (de) | Verfahren zur herstellung von diphenylaether-derivaten | |
| DD131028A5 (de) | Verfahren zur herstellung von pregnan-derivaten | |
| AT352914B (de) | Verfahren zur herstellung von polyen- verbindungen | |
| DD122964A5 (de) | Verfahren zur herstellung von prostensaeurederivaten | |
| DD128709A5 (de) | Verfahren zur herstellung von dekahydrochinolinderivaten |